Y.D. More Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Y.D. More Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6M	Hold	12,500	–	–	0.06%	87
2025 Q4	$1.52M	Buy	+12,500	New	+$1.43M	0.07%	100
2025 Q1	–	Sell	-7,565	Closed	-$681K	–	496
2024 Q4	$681K	Sell	7,565 -35	-0.5%	-$3.39K	0.06%	126
2024 Q3	$751K	Buy	7,600 +2,000	+36%	+$197K	0.08%	121
2024 Q2	$519K	Hold	5,600	–	–	0.05%	133
2024 Q1	$531K	Hold	5,600	–	–	0.09%	114
2023 Q4	$500K	Buy	5,600 +5,500	+5,500%	+$408K	0.1%	109
2023 Q3	$7.3K	Sell	100 -75	-43%	-$5.99K	﹤0.01%	316
2023 Q2	$14.6K	Sell	175 -3,627	-95%	-$303K	﹤0.01%	275
2023 Q1	$290K	Buy	3,802 +62	+2%	+$5.14K	0.07%	114
2022 Q4	$308K	Buy	+3,740	New	+$303K	0.07%	130

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Y.D. More Investments's XBI Position: Q1 2026 in Review

Y.D. More Investments held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 12,500 shares worth $1.6M. The position accounts for 0.06% of the portfolio, ranked #87.

Y.D. More Investments first reported a position in XBI in Q4 2022 and has held it in 11 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Y.D. More Investments held 12,500 shares of State Street SPDR S&P Biotech ETF worth $1.6M as of Q1 2026.
Y.D. More Investments left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.06% of Y.D. More Investments's portfolio in Q1 2026, its #87 holding.
Y.D. More Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 11 quarters since.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Y.D. More Investments's 13F filing for Q1 2026, filed 4 May 2026.